Do CRISPR Germline Ethics Statements Cut It?
Open Access
- 1 April 2018
- journal article
- research article
- Published by Mary Ann Liebert Inc in The CRISPR Journal
- Vol. 1 (2), 115-125
- https://doi.org/10.1089/crispr.2017.0024
Abstract
The extraordinary wave of genomic-engineering innovation, driven by CRISPR-Cas9, has sparked worldwide scientific and ethical uncertainty. Great concern has arisen across the globe about whether heritable genome editing should be permissible in humans—that is, whether it is morally acceptable to modify genomic material such that the “edit” is transferable to future generations. Here I examine 61 ethics statements released by the international community within the past 3 years about this controversial issue and consider the statements' overarching positions and limitations. Despite their inability to fully address all important considerations, many of the statements may advance debate and national and international law and public policy.This publication has 16 references indexed in Scilit:
- Compelling Reasons for Repairing Human GermlinesNew England Journal of Medicine, 2017
- Correction of a pathogenic gene mutation in human embryosNature, 2017
- Human Germline Genome EditingAmerican Journal of Human Genetics, 2017
- Fostering responsible research with genome editing technologies: a European perspectiveTransgenic Research, 2017
- Introducing precise genetic modifications into human 3PN embryos by CRISPR/Cas-mediated genome editingJournal of Assisted Reproduction and Genetics, 2016
- CRISPR: A path through the thicketNature, 2015
- ASGCT and JSGT Joint Position Statement on Human Genomic EditingMolecular Therapy, 2015
- CRISPR/Cas9-mediated gene editing in human tripronuclear zygotesProtein & Cell, 2015
- A prudent path forward for genomic engineering and germline gene modificationScience, 2015
- Ethics of Cancer Gene Transfer Clinical ResearchPublished by Springer Science and Business Media LLC ,2015